[PERSON]
Shinya Yamanaka
Featured in 2 tracked stories · first seen
Situations
Life Biosciences ER-100 eye gene therapy trial
9 clusters · 33 sources · last updated
Latest: Life Biosciences' ER‑100 Gene Therapy Administered to First Patient for Glaucoma
The Phase‑1 safety study of Life Biosciences’ ER‑100 eye‑gene therapy moved from its inaugural dose on 9 June 2026 to active enrollment by mid‑July, targeting up to 18 adults with open‑angle glaucoma or non‑arteritic ant
Bryan Johnson's iPSC 'baby‑Bryan' clone
4 clusters · 31 sources · last updated
Latest: Bryan Johnson Announces Lab‑Created ‘Baby‑Bryan’ Clone Using Stem‑Cell Reprogramming
On 22 July 2026 Johnson announced the creation of an iPSC‑derived “baby‑Bryan” line, describing it as a personal blood donor and a platform for anti‑aging drug testing. He linked the work to a recent diagnosis of autoimm